Surrozen, Inc. Form 8-K Summary
Business Context and Reporting Period
Surrozen, Inc. filed this Form 8-K regarding its 2022 Annual Meeting of Stockholders, held on June 7, 2022. The report was signed and filed on June 14, 2022. As of the April 11, 2022 record date, 35,125,886 common shares were entitled to vote, and 22,468,813 shares were represented at the meeting.
Financial and Operating Metrics
This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating or financial performance metrics.
Material Changes Versus the Prior Comparable Period
The filing does not report comparative-period financial results or material changes in the Company’s financial condition or operations.
Meeting Results, Outlook, and Other Matters
- Director elections: Tim Kutzkey, Ph.D., received 20,514,695 votes for, no votes against, 903,142 abstentions, and 1,050,976 broker non-votes. Anna Berkenblit, M.D., received 20,514,693 votes for, no votes against, 903,144 abstentions, and 1,050,976 broker non-votes. Both nominees were elected to serve until the 2025 Annual Meeting and until their successors are elected and qualified.
- Independent auditor: Shareholders approved the appointment of Ernst & Young LLP for the fiscal year ending December 31, 2022, with 22,467,087 votes for, 1,702 against, and 24 abstentions.
- Inconsistency in filing text: The introductory description of Proposal 2 refers to ratifying Deloitte & Touche LLP, while the detailed voting results and conclusion refer to Ernst & Young LLP. The filing text does not clarify which firm was intended.
- No other matters were submitted to a shareholder vote. The filing provides no management guidance, outlook, risk update, contingency disclosure, or unusual financial item.
Important Facts for Investors to Verify
- Confirm whether Ernst & Young LLP or Deloitte & Touche LLP was appointed as the independent registered public accounting firm for fiscal 2022.
- Verify the director election terms and the reported vote counts, including broker non-votes.
- Review the Company’s applicable periodic financial filings for financial performance, cash runway, liquidity, debt, and operating outlook, none of which are addressed in this Form 8-K.